Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesBeginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Deferred Taxes (2020 - 2022)

BioCorRx (BICX) has disclosed Deferred Taxes for 3 consecutive years, with -$28829.0 as the latest value for Q1 2022.

  • Quarterly Deferred Taxes fell 12.78% to -$28829.0 in Q1 2022 from the year-ago period, while the trailing twelve-month figure was -$109556.0 through Mar 2022, down 20.63% year-over-year, with the annual reading at -$106290.0 for FY2021, 26.85% down from the prior year.
  • Deferred Taxes hit -$28829.0 in Q1 2022 for BioCorRx, down from -$27969.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of -$18534.0 in Q1 2020 to a low of -$28829.0 in Q1 2022.
  • Historically, Deferred Taxes has averaged -$24323.2 across 3 years, with a median of -$25563.0 in 2021.
  • Biggest five-year swings in Deferred Taxes: tumbled 37.93% in 2021 and later fell 12.78% in 2022.
  • Year by year, Deferred Taxes stood at -$24775.0 in 2020, then dropped by 12.89% to -$27969.0 in 2021, then fell by 3.07% to -$28829.0 in 2022.
  • Business Quant data shows Deferred Taxes for BICX at -$28829.0 in Q1 2022, -$27969.0 in Q4 2021, and -$26680.0 in Q3 2021.